Senores Pharmaceuticals Ltd., Paras Defence and Space Technologies Ltd., Kalyani Steels Ltd. and Glenmark Pharmaceuticals Ltd ...

GIFT Nifty was trading up 0.14% to 24,597, which indicates a higher start for domestic indices. Here are the top stocks to ...

Discover insights from Corcept Therapeutics' Q1 2025 earnings call: revenue growth, relacorilant's FDA review, and its strategic outlook ...

We recently published a list of 11 Best Breakout Stocks to Buy According to Analysts. In this article, we are going to take a ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Berkshire ...

CG Oncology Inc.’s latest research effort to treat bladder cancer is impressing investors.The Irvine-based biopharmaceutical ...

Three Motley Fool contributors think they've found no-brainer healthcare stocks to buy in May. Here's why they picked Eli ...

CRISPR Therapeutics and Intellia face 2025 volatility, but CRSP’s strong cash and launches make it more attractive than NTLA.

This stock is starting the week strongly. But why? Let's find out. The post Why is this ASX All Ords stock surging 14% today?

Nanocap Alterity Therapeutics (ASX:ATH), dual-listed on both the ASX and the NASDAQ, is the latest Aussie biotech to win an ...

Private lender Kotak Mahindra Bank reported its March quarter results for the financial year 2025, posting a 14% YoY dip in ...

Tom Yeung here with your Sunday Digest. Last month, I wrote about five stocks to “buy the dip.” Our quantitative systems signaled April’s selloff had gone too far and that low prices would be enough ...